References
- Benavente-García O, Castillo J. (2008). Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem, 56, 6185–6205.
- Castillo J, Benavente O, Del Río JA. (1992). Naringin and neohesperidin levels during development of leaves, flower buds, and fruits of Citrus aurantium. Plant Physiol, 99, 67–73.
- Chen JC, Li LJ, Wen SM, He YC, Liu HX, Zheng QS. (2009). [Anti-inflammatory effects and quantitative study of the combinations of active ingredients of Painong powder in mice]. Zhong Xi Yi Jie He Xue Bao, 7, 541–545.
- Fujisawa H, Kondo S, Wang B, Shivji GM, Sauder DN. (1997). The expression and modulation of IFN-alpha and IFN-beta in human keratinocytes. J Interferon Cytokine Res, 17, 721–725.
- Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I. (1998). RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol, 138, 63–70.
- Homey B, Meller S, Savinko T, Alenius H, Lauerma A. (2007). Modulation of chemokines by staphylococcal superantigen in atopic dermatitis. Chem Immunol Allergy, 93, 181–194.
- Jourdan PS, Weiler EW, Mansell RL. (1985). Naringin levels in citrus tissues: I. Comparison of different antibodies and tracers for the radioimmunossay of naringin. Plant Physiol, 77, 896–902.
- Krueger JG, Bowcock A. (2005). Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis, 64 (Suppl 2), ii30–ii36.
- Limasset B, le Doucen C, Dore JC, Ojasoo T, Damon M, Crastes de Paulet A. (1993). Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Multivariate analysis of structure–activity relationships (SAR). Biochem Pharmacol, 46, 1257–1271.
- Luger TA, Schwarz T. (1990). Evidence for an epidermal cytokine network. J Invest Dermatol, 95, 100S–104S.
- Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J. (2004). NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant, 19, 2505–2512.
- Moriuchi H, Moriuchi M, Fauci AS. (1997). Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol, 158, 3483–3491.
- Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. (1991). Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol, 9, 617–648.
- Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, Krampert M, Goebeler M, Gillitzer R, Israel A, Krieg T, Rajewsky K, Haase I. (2002). TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature, 417, 861–866.
- Pattison JM, Nelson PJ, Krensky AM. (1995). The RANTES chemokine: A new target for immunomodulatory therapy? Clin Immunother, 4, 1–8.
- Raychaudhuri SP, Jiang WY, Farber EM, Schall TJ, Ruff MR, Pert CB. (1999). Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis. Acta Derm Venereol, 79, 9–11.
- Schall TJ. (1991). Biology of the RANTES/SIS cytokine family. Cytokine, 3, 165–183.
- Tsai SH, Lin-Shiau SY, Lin JK. (1999). Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol, 126, 673–680.
- Zhang M, Zhu L, Feng Y, Yang Y, Liu L, Ran Y. (2008). Effects of acitretin on proliferative inhibition and RANTES production of HaCaT cells. Arch Dermatol Res, 300, 575–581.